A sentinel lymph node biopsy is a medical procedure, which involves identification, removal, and examination of the lymph node to verify the presence of cancer cells. Lymph nodes are a part of the lymphatic system which is found throughout the body and is connected to the lymph vessels. Breast cancer, melanoma, colon cancer, esophageal cancer, head and neck cancer, non-small cell lung cancer, stomach cancer, thyroid cancer are various indications for biopsy. The procedure helps the healthcare provider to determine the stage of cancer, its metastasis in order to plan a line of treatment for the patient.
Rising prevalence of various types of cancer such as breast cancer, melanoma, colon cancer and growing emphasis on women healthcare are the major drivers for the growth of the market. Additionally, increasing number of health problems women further fuel the market growth. Demand for diagnosis and treatment of breast cancer and the technologically advanced medical device is found to be increasing across the globe. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Extensive research in the field of reproductive health and diseases also boost the market. Increasing demand for new products and accessories with advent of technology in the healthcare industry also fuels the growth of the market across the globe. However, various factors restrained the market growth such as complications associated with the biopsy and unawareness among women.
The global sentinel node biopsy market is expected to grow at a CAGR of 5.1% during the forecast period.
Key Players in the Global Sentinel Node Biopsy Market
Some of the key players in this market are Devicor Medical Products, Inc., part of Leica Biosystems. (Germany), C. R. Bard, Inc. (U.S.), INTRAMEDICAL IMAGING LLC (U.S.), Hilfe Engineering Corporation (India), Surgic Eye (Germany), KUB Technologies, Inc. (U.S.), Navidea Biopharmaceuticals, Inc.(U.S.) and others.
Sentinel Node Biopsy Market Segments
The global sentinel node biopsy market is segmented on the basic product, indication, and end user.
On the basis of product, the sentinel node biopsy market is segmented into breast localization wire, tissue marker, gamma probe, drainage catheter, and others
On the basis of indication, the sentinel node biopsy market is segmented into breast cancer, melanoma, colon cancer, esophageal cancer, and others.
On the basis of the end user, the sentinel node biopsy market is segmented into hospitals & clinics, diagnostic centers, and others.
Request Customization
Get a Sample
Get a Sample
Request Customization